Clinical Trial

Need to be Needed (N2BN) Intervention

Study acronym: N2BN RCT
Recruiting
View on ClinicalTrials.gov →
Summary
The proposed study is a randomized, controlled trial (RCT) that will examine the effectiveness of an intervention designed to reduce social isolation and loneliness of adults with serious mental illness (SMI). The intervention will focus on improving their sense of mattering by using acts of kindness and experiencing gratitude through volunteering. 120 participants will be randomly assigned to the intervention group or the attention control group. Over the course of the 6-month intervention, participants in the intervention arm, will receive weekly support from the interventionist. The interventionist and the participant will collaboratively set goals and develop an initial intervention plan, which is informed by the participants interests, values and goals. The attention control group will receive non-directive listening support through research assistants. Data collection for all participants will occur at baseline, at the mid-point of the intervention at 3 months, and at the end of the 6-month intervention. Participants will be asked questions about quality of experience, social context and satisfaction, mattering components, kindness, gratitude, and loneliness. We will gather data on demographic background, life transitions, social network characteristics, internalized stigma, neighborhood climate, depression, and trait measures of mattering and loneliness during intake and exit interviews. Additionally, participants of the intervention arm will be asked to provide feedback about the intervention.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-14; most recent amendment 2026-01-16.
Status change: Not Yet Recruiting → Recruiting 2026-01-16
Trial Details
NCT Number NCT06510439
Lead Sponsor Temple University
Collaborators: National Institute on Disability, Independent Living, and Rehabilitation Research
Conditions Loneliness, Social Isolation
Enrollment 120 participants
Start Date 2024-10-07
Primary Completion 2027-07-30 (estimated)
Study Completion 2035-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-21